SILVER SPRING, Md., June 20, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration approved Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin hydrochloride) as additions to diet and exercise to improve blood sugar control in children 10 years and older with type 2 diabetes. These approvals provide a new class of medicines taken by mouth … Read more
It’s 2023 and there’s still time! FORT LAUDERDALE, Fla., June 20, 2023 /PRNewswire/ — Released in March 2020, the Employee Retention Credit (ERC) was created as part of the CARES Act in response to the economic impact of the pandemic. This program was designed to encourage employers to keep their employees on the payroll, even if … Read more
NEW YORK, June 20, 2023 /PRNewswire/ — Prominently featured in The Inner Circle, Helen Khilkin-Sogoloff is recognized as a Pinnacle Life Professional for her contributions to the field of Osteopathic Medicine. Dr. Khilkin-Sogoloff pursued a Doctor of Osteopathic Medicine degree from the New York College of Osteopathic Medicine in 1994. She then completed an internship at … Read more
PALMER’S BRANCH, Texas, June 20, 2023 /PRNewswire/ — Prominently featured in The Inner Circle, Andrew Garrett is acknowledged as a Distinguished Healthcare Professional for his contributions to the field of Chiropractic. Dr. Garrett pursued higher education at the University of Texas at El Paso where he earned a Bachelor of Science in 2000. He then … Read more
DUBLIN, June 20, 2023 /PRNewswire/ — The “Hematologic Malignancies Testing Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027” report has been added to ResearchAndMarkets.com’s offering. The global hematologic malignancies testing market is anticipated to observe impressive growth during the forecast period 2023-2027 The major factors, including growing occurrences of blood cancer and extensive … Read more
SAN DIEGO, June 20, 2023 /PRNewswire/ — Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers, today announced that on June 20, 2023, non-qualified stock option awards to purchase an aggregate of 40,032 shares of its common stock were granted to one new … Read more
AUSTIN, June 20, 2023 /PRNewswire/ — The University of Texas System Board of Regents is expanding its investment in student mental health services with the launch of a new program that will offer free, virtual mental health support to students at all 14 UT institutions beginning in the 2023 fall semester. The new program will … Read more
WASHINGTON, June 20, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the second quarter 2023 on Tuesday, July 25, 2023 beginning at 8:00 a.m. ET and lasting approximately 1 hour. During the call, the company will discuss its financial performance, as well as future expectations. The … Read more
BURNSVILLE, Minn., June 20, 2023 /PRNewswire/ — Inspired Spine SurgCenter is thrilled to announce the grand opening of its state-of-the-art facility in Burnsville, MN. Located at 1601 Hwy 13 E, Burnsville, MN 55337, the new center represents a significant milestone in advanced surgical care. Alongside the grand opening, Inspired Spine SurgCenter is proud to introduce … Read more
DENVER, June 20, 2023 /PRNewswire/ — ALPS Advisors, Inc., acquired by SS&C, providing products and services to the financial services industry, today announced The Fund – ALPS Hillman Active Value ETF (NYSE ARCA: HVAL) – will close to new investors on July 26, 2023 and liquidate on July 28, 2023. The decision to close the … Read more